Also trades as: RAFLF (OTC) · $vol 0M
BSL.SI SES
Raffles Medical Group Ltd
1W: -1.2%
1M: -4.7%
3M: -10.9%
YTD: -19.6%
1Y: -19.6%
3Y: -31.1%
5Y: -35.4%
S$0.82 ($0.64)
+0.01 (+0.61%)
Weekly Expected Move ±1.6%
S$1
S$1
S$1
S$1
S$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$1.4B
-6.6% ▼
5Y CAGR: +0.4%
Total Liabilities
$374M
-19.7% ▼
5Y CAGR: -5.3%
Shareholders Equity
$1.1B
+0.8% ▲
5Y CAGR: +3.3%
Cash & Investments
$311M
-9.6% ▼
5Y CAGR: +8.9%
Total Debt
$115M
+30.3% ▲
5Y CAGR: -13.2%
Net Debt
-$196M
+23.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $265M | $253M | $344M | $344M | $311M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $265M | $253M | $344M | $344M | $311M |
| Net Receivables | $161M | $228M | $56M | $162M | $114M |
| Inventory | $13M | $13M | $12M | $11M | $11M |
| Other Current Assets | -$3M | $0 | $0 | $0 | $0 |
| Total Current Assets | $439M | $494M | $485M | $516M | $436M |
| Property, Plant & Equip. | $797M | $739M | $768M | $748M | $741M |
| Goodwill & Intangibles | $32M | $20M | $19M | $15M | $14M |
| Long-Term Investments | $276M | $276M | $254M | $249M | $237M |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $1.1B | $1.0B | $1.0B | $1.0B | $994M |
| Total Assets | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B |
| — Liabilities — | |||||
| Accounts Payable | $222M | $157M | $211M | $218M | $185M |
| Short-Term Debt | $96M | $10M | $18M | $7M | $60M |
| Deferred Revenue | $2M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $57M | $85M | $143M | $122M | $65M |
| Total Current Liabilities | $417M | $363M | $379M | $382M | $334M |
| Long-Term Debt | $78M | $63M | $69M | $49M | $27M |
| Other Non-Current Liab. | $50M | $56M | $15M | $4M | -$22M |
| Total Non-Current Liabilities | $152M | $142M | $105M | $84M | $40M |
| Total Liabilities | $569M | $467M | $484M | $466M | $374M |
| — Equity — | |||||
| Common Stock | $426M | $432M | $440M | $440M | $440M |
| Retained Earnings | $484M | $575M | $592M | $610M | $634M |
| Accumulated OCI | $50M | $34M | $27M | $30M | $17M |
| Total Stockholders Equity | $961M | $1.0B | $1.0B | $1.0B | $1.1B |
| Total Liabilities & Equity | $1.5B | $1.5B | $1.5B | $1.5B | $1.4B |
| — Key Metrics — | |||||
| Total Debt | $198M | $96M | $125M | $88M | $115M |
| Net Debt | -$67M | -$157M | -$219M | -$256M | -$196M |
| Total Investments | $276M | $276M | $254M | $249M | $237M |